2.Contractile effect of ultraviolet in isolated rat thoracic aorta.
Seung Ho KWAK ; Bong Su RYU ; Hwan Ig KIM ; Sam Yong LEE ; Paek Hyeon CHO
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1993;20(2):248-257
No abstract available.
Animals
;
Aorta, Thoracic*
;
Rats*
3.A clinical review of the polydactyly.
Bong Su RYU ; Seung Ho KWAK ; Hwan Ik KIM ; Sam Yong LEE ; Peak Hyeon CHO
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1993;20(4):724-733
No abstract available.
Polydactyly*
4.Treatment of the Earlobe Keloid with Preservation of the Piercing for an Earring.
Yang Soo KANG ; Hong Cheol RIM ; Bong Su RYU ; Myong Ju LEE ; Jeong Yeol YANG
Journal of the Korean Society of Aesthetic Plastic Surgery 1998;4(1):135-140
In the East, Probably one of the most commonly performed esthetic operation is the piercing of the earlobes for earring. the complication of this procedure includes infection, the formation of the hypertrophic scar or keloid, and tearing. Keloid formation is one of the disaterous common complications of the ear piercing. the patients regard the keloid as a cosmetic blemish and they complain that they cannot wear earrings. We have experienced 5 patients of earlobe keloid complicated from piercing of the earlobes. We used intralestional steroid njection, in conjunction with surgical excision and pressure therapy for treatment of the keloid. Among various techniques for reconstructing a piercing, we chose modified Pardue's method for artificial earlobe cleft after wide excision of the keloid. the result was good and satisfactory without any complication after 4 to 24 months of follow-up. the purpose of this paper is to present a simple method of treatment of the earlobe keloid with preservation of the perforation for an earring.
Body Piercing
;
Cicatrix, Hypertrophic
;
Ear*
;
Follow-Up Studies
;
Humans
;
Keloid*
5.Inhibitory Mechanism of Periaqueductal Gray Matter on Neuropathic Pain in Rat.
Bong Ok KIM ; Jae Wook RYU ; Jeong Su SEO ; Jin Hoon SOHN
Journal of the Korean Academy of Rehabilitation Medicine 2001;25(1):110-116
OBJECTIVE: Using Lee et al (1996) model, we assessed the effect of opioid within the PAG on the manifestations of the neuropathic pain, and we studied the effects of naloxone on the analgesic effects of opioid. METHOD: Under pentobarbital anesthesia, male Sprague-Dawley rats were implanted with cannula in the ventral (n=10) and dorsal (n=6) PAG after the unilateral tibial and sural nerves were ligated and cut, leaving the common peroneal nerve intact. Pain sensitivity was assessed using the von Frey filament (8 mN) and acetone applied to the sensitive area for 1 week postoperatively. Rats with neuropathic pain were intracerebrally microinjected with DAMGO (0.1microgram/5microliter) and enkephaline (20microgram/5microliter) into the ventral and dorsal PAG and the pain sensitivity was assessed. Naloxone was injected to assess the observed change of pain sensitivity. RESULTS: Intracerebral microinjection of DAMGO and enkephaline into the ventral PAG, but not the dorsal PAG, increased the pain threshold which was reversed by naloxone. CONCLUSION: The results suggest that stimulation of the ventral PAG in neuropathic rats may reduce neuropathic pain via opioid-mediating pathway of the descending pain inhibition system.
Acetone
;
Anesthesia
;
Animals
;
Catheters
;
Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
;
Enkephalins
;
Humans
;
Male
;
Microinjections
;
Naloxone
;
Neuralgia*
;
Pain Threshold
;
Pentobarbital
;
Periaqueductal Gray*
;
Peroneal Nerve
;
Rats*
;
Rats, Sprague-Dawley
;
Sural Nerve
6.Comparison of disinfective power according to application order of 70% isopropyl alcohol and 10% povidone-iodine.
Sang Su KIM ; Soo Bong YU ; Joo Duck KIM ; Sie Jeong RYU
Korean Journal of Anesthesiology 2013;65(6):519-524
BACKGROUND: Many disinfectants have been used clinically in both single and combination applications, but there have been few studies on disinfective power according to sterilization sequence when using a combination of disinfectants. The purpose of this study was to evaluate the disinfective power of a combination of 70% isopropyl alcohol and 10% povidone-iodine (PVP-I) according to sterilization sequence. METHODS: Two hundred healthy volunteers were recruited. Subjects were disinfected with a combination of 70% isopropyl alcohol and 10% PVP-I on both forearms, in varying sequence. The AP group included disinfections on the left forearm with isopropyl alcohol first followed by 10% PVP-I, while the PA group included disinfections on the right forearm with same disinfectants in reverse order. Skin cultures were obtained using cotton swabs 3 min after application of each disinfectant, and then were inoculated on blood agar plates for bacterial culture. Cultures were incubated at 37degrees C under aerobic conditions for 48 hours. RESULTS: There was no significant difference in the number of positive cultures after the 1st disinfection (AP, 45; PA, 36, P = 0.262) or the 2nd disinfection (AP, 6; PA, 13, P = 0.157), suggesting that there is no relationship between disinfective power and the sequence of the disinfectants used. The number of positive cultures significantly decreased after the 2nd disinfection (P < 0.01), however. CONCLUSIONS: There was no significant difference in disinfective power according to sterilization sequence with 70% isopropyl alcohol and 10% PVP-I in healthy volunteers. The combination of 70% isopropyl alcohol and 10% PVP-I was more effective than disinfection with a single agent regardless of sterilization sequence.
2-Propanol*
;
Agar
;
Disinfectants
;
Disinfection
;
Forearm
;
Healthy Volunteers
;
Povidone-Iodine*
;
Skin
;
Sterilization
7.A Case of Tuberculous Pneumonitis With Continuous High Spiking Fever.
Hee Seung LEE ; Jung Cheol RYU ; Tae Koon PARK ; Tae Joon PARK ; Eun Soo YANG ; Soo Jeon CHOI ; Young Tace KWAK ; Bong Su CHA ; Se Kyu KIM
Tuberculosis and Respiratory Diseases 1994;41(3):299-302
A 33-year old male was admitted due to continuous high spiking fever for 2 months via local clinic. He had been diagnosed pulmonary tuberculosis at local clinic. However, spiking fever had not been controlled by anti-tuberculous medications. Chest PA showed confluent consolidation on right upper & mid-lung field. 5 anti-tuberculous regimens (Streptomycin, Isoniazid, Rifampin, Ethambutol, Pyrazinamaide) were administered initially and steroid therapy was followed for relieving toxic symptoms Very slowly resolved chest X-ray lesion and continuous fever suggested the possibility of misdiagnosis. After 60th hospital day, the chest X-ray lesion was resolved gradually and fever subsided almost completely. He was discharged on 76th hospital day with anti-tuberculous drugs and steroid(prednisolon), without any other problems except sustained mild fever.
Diagnostic Errors
;
Ethambutol
;
Fever*
;
Humans
;
Isoniazid
;
Male
;
Pneumonia*
;
Rifampin
;
Thorax
;
Tuberculosis, Pulmonary
8.Clinical outcomes of esophageal squamous cell carcinoma in patients aged over 80 years
Dae Gon RYU ; Cheol Woong CHOI ; Su Jin KIM ; Su Bum PARK ; Jin Ook JANG ; Bong Soo SON
The Korean Journal of Internal Medicine 2025;40(2):230-242
Background/Aims:
The clinical outcomes and optimal treatment of esophageal squamous cell carcinoma (ESCC) in elderly patients are unclear. This study aimed to assess the clinical outcomes of ESCC in patients aged ≥ 80 years.
Methods:
Medical records of patients diagnosed with ESCC between December 2008 and February 2024 were retrospectively reviewed. In total, 479 patients with ESCC were included and divided into the elderly (n = 52) and younger (n = 427) groups based on age. The clinical outcomes and survival rates, according to treatment, were compared between the two groups.
Results:
The median ages of the two groups were 82 years (range, 80–95 yr) and 66 years (41–79 yr). The overall survival was slightly lower in the elderly group; however, no statistical significance (hazard ratio [HR] 1.27, 95% confidence interval [CI] 0.85−1.91; p = 0.238) was observed. No differences were observed in the outcomes or survival between the two groups according to the treatment method (surgery, chemoradiotherapy or radiotherapy alone, and endoscopic resection). The elderly group was more likely to receive no treatment for cancer (30.8% vs. 13.6%, p = 0.002) than the younger group. However, when there was no treatment for cancer in the elderly group, survival was significantly lower than when treatment was administered (HR 0.08, 95% CI 0.03−020; p < 0.001).
Conclusions
In patients with ESCC aged ≥ 80 years, active cancer treatment was beneficial, and the results did not differ from those of younger patients.
9.Clinical outcomes of esophageal squamous cell carcinoma in patients aged over 80 years
Dae Gon RYU ; Cheol Woong CHOI ; Su Jin KIM ; Su Bum PARK ; Jin Ook JANG ; Bong Soo SON
The Korean Journal of Internal Medicine 2025;40(2):230-242
Background/Aims:
The clinical outcomes and optimal treatment of esophageal squamous cell carcinoma (ESCC) in elderly patients are unclear. This study aimed to assess the clinical outcomes of ESCC in patients aged ≥ 80 years.
Methods:
Medical records of patients diagnosed with ESCC between December 2008 and February 2024 were retrospectively reviewed. In total, 479 patients with ESCC were included and divided into the elderly (n = 52) and younger (n = 427) groups based on age. The clinical outcomes and survival rates, according to treatment, were compared between the two groups.
Results:
The median ages of the two groups were 82 years (range, 80–95 yr) and 66 years (41–79 yr). The overall survival was slightly lower in the elderly group; however, no statistical significance (hazard ratio [HR] 1.27, 95% confidence interval [CI] 0.85−1.91; p = 0.238) was observed. No differences were observed in the outcomes or survival between the two groups according to the treatment method (surgery, chemoradiotherapy or radiotherapy alone, and endoscopic resection). The elderly group was more likely to receive no treatment for cancer (30.8% vs. 13.6%, p = 0.002) than the younger group. However, when there was no treatment for cancer in the elderly group, survival was significantly lower than when treatment was administered (HR 0.08, 95% CI 0.03−020; p < 0.001).
Conclusions
In patients with ESCC aged ≥ 80 years, active cancer treatment was beneficial, and the results did not differ from those of younger patients.
10.Clinical outcomes of esophageal squamous cell carcinoma in patients aged over 80 years
Dae Gon RYU ; Cheol Woong CHOI ; Su Jin KIM ; Su Bum PARK ; Jin Ook JANG ; Bong Soo SON
The Korean Journal of Internal Medicine 2025;40(2):230-242
Background/Aims:
The clinical outcomes and optimal treatment of esophageal squamous cell carcinoma (ESCC) in elderly patients are unclear. This study aimed to assess the clinical outcomes of ESCC in patients aged ≥ 80 years.
Methods:
Medical records of patients diagnosed with ESCC between December 2008 and February 2024 were retrospectively reviewed. In total, 479 patients with ESCC were included and divided into the elderly (n = 52) and younger (n = 427) groups based on age. The clinical outcomes and survival rates, according to treatment, were compared between the two groups.
Results:
The median ages of the two groups were 82 years (range, 80–95 yr) and 66 years (41–79 yr). The overall survival was slightly lower in the elderly group; however, no statistical significance (hazard ratio [HR] 1.27, 95% confidence interval [CI] 0.85−1.91; p = 0.238) was observed. No differences were observed in the outcomes or survival between the two groups according to the treatment method (surgery, chemoradiotherapy or radiotherapy alone, and endoscopic resection). The elderly group was more likely to receive no treatment for cancer (30.8% vs. 13.6%, p = 0.002) than the younger group. However, when there was no treatment for cancer in the elderly group, survival was significantly lower than when treatment was administered (HR 0.08, 95% CI 0.03−020; p < 0.001).
Conclusions
In patients with ESCC aged ≥ 80 years, active cancer treatment was beneficial, and the results did not differ from those of younger patients.